Lumos Diagnostics Holdings Limited

ASX:LDX.AX

0.032 (AUD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 4.1834.1831.3831.3832.7242.7242.5442.5443.2143.2142.6012.6015.2245.2244.2044.2041.7211.5331.1961.151
Cost of Revenue 1.6191.6190.6660.6661.0421.0421.3671.3673.4773.4771.4011.4013.2683.2681.8591.8590.9970.8890.6540.63
Gross Profit 2.5642.5640.7180.7181.6831.6831.1771.177-0.263-0.2631.2011.2011.9561.9562.3452.3450.7230.6450.5420.521
Gross Profit Ratio 0.6130.6130.5190.5190.6180.6180.4630.463-0.082-0.0820.4620.4620.3740.3740.5580.5580.420.420.4530.453
Reseach & Development Expenses 0.0210.0210.0550.0550.0010.0010.1290.1290.5180.5180.1460.1460.2890.2890.3310.3310.6530.5820.3860.371
General & Administrative Expenses 0.3830.3831.0461.0460.8640.8641.2071.2071.6011.6012.7942.7942.0712.0712.8142.8143.0972.761.6811.617
Selling & Marketing Expenses 0.120.120.0250.0250.1540.1540.0870.0870.570.570.5650.5650.0280.0280.4890.4890.490.4370.4250.409
SG&A 2.8982.8982.8542.8542.7882.7882.9822.9826.2756.2755.9415.9415.885.883.3033.3033.5873.1972.1062.026
Other Expenses 00000000000000000000
Operating Expenses 2.9182.9182.9093.5231.7991.7994.3514.35116.87816.8786.6366.6366.1276.1273.583.583.2262.8752.4872.392
Operating Income -0.354-0.354-2.191-2.815-1.927-1.927-2.909-2.909-8.015-8.015-5.436-5.436-4.212-4.212-1.289-1.289-3.447-3.071-1.945-1.871
Operating Income Ratio -0.085-0.085-1.584-2.035-0.707-0.707-1.144-1.144-2.494-2.494-2.09-2.09-0.806-0.806-0.307-0.307-2.003-2.003-1.626-1.626
Total Other Income Expenses Net -0.736-0.736-1.016-0.3920.7230.723-0.374-0.374-9.303-9.303-0.108-0.108-1.644-1.644-0.371-0.3710.9270.826-0.241-0.232
Income Before Tax -1.09-1.09-3.207-3.207-1.204-1.204-3.282-3.282-17.318-17.318-5.544-5.544-5.856-5.856-1.66-1.66-2.519-2.245-2.186-2.103
Income Before Tax Ratio -0.26-0.26-2.319-2.319-0.442-0.442-1.29-1.29-5.388-5.388-2.131-2.131-1.121-1.121-0.395-0.395-1.464-1.464-1.828-1.828
Income Tax Expense -0.66-0.66-0.62400000000000000.030.02600
Net Income -1.09-1.09-3.207-3.207-1.204-1.204-3.282-3.282-17.318-17.318-5.544-5.544-5.856-5.856-1.66-1.66-2.49-2.218-2.186-2.103
Net Income Ratio -0.26-0.26-2.319-2.319-0.442-0.442-1.29-1.29-5.388-5.388-2.131-2.131-1.121-1.121-0.395-0.395-1.447-1.447-1.828-1.828
EPS -0.002-0.002-0.007-0.007-0.005-0.005-0.016-0.016-0.11-0.11-0.037-0.03700-0.019-0.019-0.096000
EPS Diluted -0.002-0.002-0.007-0.007-0.005-0.005-0.016-0.016-0.11-0.11-0.037-0.03700-0.019-0.019-0.096000
EBITDA -0.842-0.691-2.191-2.191-1.636-1.395-1.934-1.934-7.947-7.947-4.887-4.887-4.2-4.2-1.146-1.146-3.37-3.043-1.913-1.84
EBITDA Ratio -0.201-0.165-1.584-1.584-0.601-0.512-0.76-0.76-2.473-2.473-1.879-1.879-0.804-0.804-0.273-0.273-1.959-1.985-1.599-1.599